Search

everythinglearnresearchcommunity

for

Search:↓

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

A woman's male-like physical changes were caused by two rare ovarian conditions.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

A guinea pig with ovarian cysts had a uterine infection and abnormal uterus lining due to a piece of hay inside it.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.